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Fast-evolving MHC class I polymorphism serves to diversify NK cell and CD8 T cell responses in 
individuals, families, and populations. Because only chimpanzee and bonobo have strict orthologs of all 
HLA class I, their study gives unique perspectives on the human condition. We defined polymorphism of 
Papa-B, the bonobo ortholog of HLA-B, for six wild bonobo populations. Sequences for Papa-B exon 2 
and 3 were determined from the genomic DNA in 255 fecal samples, minimally representing 110 
individuals. Twenty-two Papa-B alleles were defined, each encoding a different Papa-B protein. No Papa-
B is identical to any chimpanzee Patr-B, human HLA-B, or gorilla Gogo-B. Phylogenetic analysis 
identified a clade of MHC-B, defined by residues 45–74 of the α1 domain, which is broadly conserved 
among bonobo, chimpanzee, and gorilla. Bonobo populations have 3–14 Papa-B allotypes. Three Papa-B 
are in all populations, and they are each of a different functional type: allotypes having the Bw4 
epitope recognized by killer cell Ig-like receptors of NK cells, allotypes having the C1 epitope also 
recognized by killer cell Ig-like receptors, and allotypes having neither epitope. For population 
Malebo, these three Papa-B are the only Papa-B allotypes.  Although  small  in number, their  
sequence  divergence  is such  that  the  nucleotide  diversity  (mean  proportional distance) of Papa-B 
in Malebo is greater than in the  other populations and is also greater than expected for random 
combinations of three Papa-B. Overall, Papa-B has substantially less diversity than Patr-B in 
chimpanzee subspecies and HLA-B in indigenous human populations, consistent with bonobo having 




In vertebrates, the MHC is a genomic region containing numerous immune system genes. Of these, the MHC 
class I and II genes are distinguished from all other vertebrate genes by the depth and breadth of their allelic 
polymorphism (1). MHC class I and II genes encode cell surface glycoproteins that bind endogenous and 
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pathogen-derived peptide Ags and present them to various families of lymphocyte receptors. Dedicated to 
adaptive immunity, MHC class II present Ags of extracellular pathogens to CD4 T cells (2, 3). In contrast, 
MHC class I function in innate immunity, adaptive immunity, and formation of the placenta during 
reproduction. During infection, MHC class I present peptide Ags of intracellular pathogens, notably viruses, 
to the receptors of NK cells of innate immunity (4) and CD8 T cells of adaptive immunity (5). During 
reproduction, MHC class I on fetal trophoblast cells present peptides of paternal origin to receptors of maternal 
uterine NK cells (6). Because of these distinctive functions, MHC class I has a more diverse and rapidly 
evolving polymorphism than MHC class II (7–9). 
 
As a consequence of the more rapid evolution of MHC class I, the only living species that have strict 
orthologs of all of the polymorphic human MHC class  I  genes, HLA-A, HLA-B, and HLA-C, are  the  great  
apes:  chimpanzee,  bonobo,  gorilla,  and orangutan (10). Coevolving with MHC-A, MHC-B, and MHC-C is 
the family of killer cell Ig-like receptors (KIRs) (6, 11). Members of this family are inhibitory and activating 
receptors that recognize a set of alternative epitopes specified by sequence motifs at residues 76–83 in the α1 
domain of MHC class I (12–16). These epitopes make up the Bw4 epitope carried by subsets of MHC-A and 
MHC-B allotypes, the C1 epitope carried by subsets of MHC-B and MHC-C allotypes, and the C2 epitope 
carried by the subset of MHC-C allotypes that lack the C1 epitope (4, 6, 11, 14, 16, 17). The interactions 
between KIRs and their MHC class I ligands are further diversified by sequence variation in the peptide bound 
by MHC class I, polymorphism at residues in MHC class I other than 76–83, and the high polymorphism of 
KIR, which rivals that of MHC class I (18–22). These interactions serve to modulate the development and 
function of NK cells (11). The diversity of MHC–KIR interactions individualizes NK cell responses, as is 
evident from the broad range of human diseases that correlate with HLA class I and KIR polymorphisms (23–
26). 
 
Comparative studies of the genetics and function of chimpanzee MHC class I (27–32) and KIRs (33–35) have 
provided a unique and valuable perspective that has increased knowledge and understanding of the human 
immune system. Providing equal opportunity for this approach is the bonobo (Pan paniscus), the sibling 
species to chimpanzee (Pan troglodytes) that is as closely related to the human species as are chimpanzees 
(36). Our previous study of captive bonobos indicated that the bonobo KIR locus had undergone a process of 
gene loss and attenuation of KIR avidity for MHC class I similar to humans (37). However, limiting the 
interpretation of those results was an almost complete lack of knowledge of the bonobo MHC. Studies of 
captive bonobos identified only eight alleles each for MHC-A and MHC-B and five alleles for MHC-C (10, 38–
42). In a recent study of the wild chimpanzee populations of Gombe National Park, Tanzania, we defined the 
polymorphism of Patr-B (Pan troglodytes) (32), the ortholog of HLA-B, the most polymorphic human MHC 
class I gene (10, 27, 32, 43, 44). That investigation required development of a method for isolating Patr-B 
from chimpanzee feces. Because of the close phylogenetic relationship of chimpanzee and bonobo, that 
method was directly applicable to the analysis of Papa-B (Pan  paniscus), the bonobo ortholog of Patr-B and 
HLA-B. In this article, we define Papa-B of wild bonobos resident at sites throughout the bonobo range in the 
Democratic Republic of Congo (DRC) (45). 
 
Materials and Methods 
 
This project is not classified as animal research by the Stanford Administrative Panel on Laboratory Animal 
Care, according to National Institutes of Health guidelines. Fecal samples from wild-living bonobos were 
collected noninvasively. Permission to collect samples in the DRC was granted by its Ministry of Scientific 
Research and Technology, Department of Ecology and Management of Plant and Animal Resources of the 
University of Kisangani, Ministries of Health and Environment, and National Ethics committee. Use of the 
Yerkes National Primate Research Center bonobo samples was approved under Stanford Administrative Panel 
on Laboratory Animal Care 9057. 
 
Study sites, sample collection, and sample typing 
 
As described by Li et al. (45), teams of local trackers collected 255 fecal samples from nonhabituated 
bonobos at six sites distributed throughout the bonobo range in the DRC: Malebo (ML), LuiKotale (LK), 
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Ikela (IK), Balanga (BN), Kokolopori (KR), and Bayandjo (BJ) (Figs. 1, 2). Samples were obtained 
opportunistically, placed into an equal volume of RNAlater (Life Technologies), and labeled with a number, 
field site code, and GPS coordinates, whenever possible. Because the field sites lack refrigeration, samples 
were kept at ambient temperature before they were frozen (typically several weeks, but up to several months 
in some cases). Samples from ML were frozen at –80˚C at the Institut National de Recherche Bio- médicale 
in Kinshasa before being sent directly to the University of Montpellier. Samples from the five other sites were 
frozen at –20˚C in the central laboratory at Kisangani, from which they were sent to the United States. DNA 
was extracted from the samples and analyzed for mitochon- drial hypervariable D-loop haplotype and by 
genotyping for four to eight microsatellite loci [Li et al. (45): LK, IK, and KR; this study: ML, BN, and BJ]. 
For the fecal samples from ML, BN, and BJ, the sex of sample donors was determined using the PCR-based 




FIGURE  1. The bonobo range and locations of the populations studied. (A) Map of Africa showing the 
range of bonobos (Pan paniscus [Pp]) and the four chimpanzee subspecies (P. troglodytes verus [Ptv; 
western], P. troglodytes ellioti [Pte; Nigeria-Cameroon], P. troglodytes troglodytes [Ptt; central], and P. 
troglodytes schweinfurthii [Pts; eastern]). The locations of the six bonobo study sites within the DRC are 
shown as white circles and are labeled with their two-letter codes. The sites are separated by distances of 
∼30–1000 km. Also marked is the location of the wild P. troglodytes schweinfurthii chimpanzee population 
in Gombe National Park, Tanzania. (B) Enlarged view of the six bonobo study sites (black circles; labeled 
with their two-letter codes) and the site of the Gombe P. troglodytes schweinfurthii chimpanzee population. 
The bonobo range is highlighted in yellow, and blue lines represent rivers in the DRC. The Lomami River 




FIGURE  2. Summary of fecal sampling and Papa-B genotyping results. (A) The number of Papa-B alleles; 
the minimum estimate of the number of individuals sampled, as determined by the combination of 
mitochondrial haplotypes and microsatellite and Papa-B genotypes (Individuals [Min]); and the number of 
fecal samples genotyped (Samples) are given for each population. West, Central, and East denote the three 
regional bonobo populations, as defined by FST distances based on mitochondrial haplotype (46). (B) 
Distribution of Papa-B alleles among individuals in the six study sites. The alleles are grouped according to 
their presence in all sites (top), two or three sites (middle), or one site (bottom). Alleles found in a single 
individual at one site were detected from one sample (1) or two (12). Previously identified Papa-B alleles are 
highlighted in gray. (C) Papa-B allele frequencies in the total study population of 110 bonobos are presented 
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in order of ascending allele number, along with the number of bonobos that possess the allele as 
heterozygotes or homozygotes. Papa-B*07:01 appears to have an excess of homozygotes, but this is because 
of the large number of homozygotes expected and observed in the ML population, which only has three 
Papa-B alleles. #Papa-B*07:01 is more frequent than the other alleles (p < 0.0001, Fisher exact test). 
 
DNA extraction and Papa-B PCR and sequencing 
 
DNA was extracted from fecal samples using the QIAamp DNA Stool Mini Kit (QIAGEN) and the protocol 
that we described earlier (32). Fecal DNA was amplified in three separate PCR reactions to yield exons 2 and 
3 of Papa-B [as described for chimpanzees by Wroblewski et al. (32)]. Exons 2 (270 bp) and 3 (276 bp) were 
targeted because they encode, respectively, the α1 and α2 domains that form the peptide binding site of MHC-
B. The α1 and α2 domains are the most variable and functionally engaged part of MHC-B. Each exon was 
amplified separately using primers designed from the intron sequences that flank the exons. These are 
conserved between chimpanzee Patr-B and bonobo Papa-B. The two standard PCR reactions produced 
amplicons of 425 bp (exon 2) and 411 bp (exon 3), similar sizes to the 137–328-bp amplicons of the bonobo 
microsatellite typing system. The third reaction was designed specifically to amplify exon 2 of alleles of the 
chimpanzee Patr-B*17 lineage (429-bp amplicon), which the standard exon 2 primers cannot amplify. This 
amplification was applied to all samples that appeared homozygous for exon 2 using the standard primers. 
However, no bonobo had an allele related to the Patr-B*17 lineage for exon 2 or exon 3. 
 
We used the forward primer to sequence all PCR products. When this sequence indicated the presence of a 
novel allele or when the sequence was ambiguous, the PCR products were cloned and sequenced. On 
detecting a candidate novel allele of Papa-B, its identity was confirmed with a second amplification, either 
from another individual or an independent amplification from the same individual. Before being applied to 
fecal DNA from wild bonobos, the standard pairs of amplification primers were validated by their capacity to 
amplify and sequence exons 2 and 3 of Papa-B from DNA extracted from PBMCs of two captive bonobos 
(Lorel [Papa-B*01:01, *07:01] and Matata [homozygous Papa-B*07:01]) obtained from the Yerkes 
Regional Primate Research Center (Atlanta, GA). Bonobo PBMCs were isolated from samples of peripheral 
blood by Ficoll gradient separation. DNA was extracted from PBMCs using the QIAamp DNA Blood Kit 
(QIAGEN). 
 
Papa-B allele inference 
 
Because exons 2 and 3 were amplified separately, we had to infer the phase of the exons to define the alleles. 
When exon 2 and 3 sequences were identical to those of a previously characterized allele (e.g., Papa-
B*07:01), they were assumed to signify that allele and were paired together (Supplemental Fig. 1A). For 
heterozygous individuals containing an exon 2 and 3 pair from a previously identified allele, the other exon 2 
and 3 pair was then inferred to define the second allele (Supplemental Fig. 1A). Most alleles (exon 2 and 3 
pairs) were amplified more than once from different fecal DNA samples (from different individuals) and in 
different heterozygous combinations. Therefore, the repeated exon pair was inferred to make up an allele, 
identifying the remaining pair as the second allele (Supplemental Fig. 1B). For all alleles observed in only 
one or two individuals at a particular site, all but one were observed in heterozygous genotypes (both for 
exons 2 and 3) with alleles commonly observed in other individuals and/or at other sites (Fig. 2, 
Supplemental Table Ia–f). This facilitated the identification of alleles according to the above criteria. In one 
exception, a novel exon 3 sequence was obtained from just one KR sample that was heterozygous for the 
exon (Fig. 2B, Supplemental Table Ie). However, it was unclear whether both exon 3 sequences shared the 
same, single exon 2 sequence obtained from the sample. Therefore, conservatively, we did not assign the 
unique exon 3 sequence a companion exon 2 sequence, and the exon 3 sequence was given the provisional 
allele name Papa-B*21:01 (Fig. 4, see Supplemental Fig. 1C for more details). 
 
Hardy–Weinberg equilibrium and allele frequency differences 
 
We used GENEPOP v4.2 (Hardy–Weinberg exact test, using probability test) to test for deviations between 
the observed genotype frequencies and those expected under Hardy–Weinberg equilibrium for all 110 
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bonobos, as well as the five well-sampled populations. GENEPOP uses the Markov chain method to estimate 
p values (51, 52). Differences in allele frequencies were tested with the Fisher exact test using GraphPad 
QuickCalcs. 
 
Phylogeny, pairwise differences, and amino acid variability 
 
Neighbor-joining trees of MHC-B nucleotide sequences were created using the Tamura–Nei model in 
MEGA6 (53), with pairwise deletion and 1000 bootstrapped replications. MEGA6 was also used to calculate 
pairwise distances between nucleotide sequences, using pairwise deletion and proportional distance (p-
distance). The difference between the mean p-distances was tested with unpaired t tests using GraphPad 
QuickCalcs. The Wu–Kabat variability coefficient was used to assess the amino acid diversity at each 
position in the α1 and α2 domains of MHC-B (54, 55). For each position in the sequence, the coefficient was 
calculated as (N*k)/n, where N is the total number of sequences, k is the number of different amino acid 
residues occurring at that position, and n is the number of sequences in which the most common amino acid 
at that position is observed. 
 
Additional MHC-B data sets 
 
Several MHC-B data sets were used to examine bonobo Papa-B variation in context. More than 4600 human 
HLA-B alleles have been identified in human populations worldwide, through the typing of prospective 
donors of hematopoietic stem cells for clinical transplantation (43). For our analyses, the HLA-B dataset was 
reduced to a set of 20 HLA-B alleles that represent all human variation (Supplemental Table Ig) (J. Robinson, 
L.A. Guethlein, N. Cereb, S.Y. Yang, P.J. Norman, S.G.E. Marsh, and P. Parham, manuscript in revision). 
Fifteen Gogo-B alleles from Western gorilla (Gorilla gorilla) and 64 Patr-B alleles from chimpanzee were 
also included. Patr-B alleles were also identified as being specific to chimpanzee subspecies (Fig. 1A): 
western P. troglodytes verus (21 alleles), central P. troglodytes troglodytes (8 alleles), and eastern P. 
troglodytes schweinfurthii (16 alleles) (32). Patr-B in the fourth chimpanzee subspecies, P. troglodytes ellioti, 
has yet to be studied. 
 
Data sets of Patr-B from two chimpanzee populations were compared with Papa-B in bonobo populations. 
One population consists of the 125 wild P. troglodytes schweinfurthii chimpanzees of Gombe National Park 
in Tanzania (32). The other includes 32 wild-born P. troglodytes verus chimpanzees from Sierra Leone that 
were used to found the captive population formerly  housed  at  the  Biomedical  Primate  Research  Center 
(BPRC) in the Netherlands (31). HLA-B allele frequencies for six human populations were included in the 
comparisons. Four are indigenous populations: the Hadza from Tanzania (56), the Tao from Taiwan (57, 58), 
the Asaro from Papua New Guinea (59), and the Yucpa from Venezuela (60). The other two human 
populations are admixed urban populations: Africans from Kampala, Uganda (61) and Europeans from 




Study of six separated bonobo populations identified 22 Papa-B alleles 
 
We studied MHC variation in bonobos resident at six sites in the DRC: ML, LK, IK, BN, KR, and BJ. These 
sites are between 30 and 1000 km apart and, collectively, they represent much of the bonobo range (Fig. 1). A 
total of 255 samples of bonobo feces was used to study Papa-B, the ortholog of chimpanzee Patr-B and 
human HLA-B. Only two fecal samples were obtained from site BJ, whereas 36–67 samples were collected 
from each of the other sites (Fig. 2A). Because almost all amino acid sequence diversity and the sites of 
functional interaction localize to the α1 and α2 domains of MHC class I (6, 11), we targeted these domains of 
Papa-B. The methods used were those developed in our study of Patr-B polymorphism in the wild 
chimpanzee population of Gombe National Park in Tanzania (32). 
 
Exon 2, encoding the α1 domain, and exon 3, encoding the α2 domain, were amplified separately by PCR 
from DNA isolated from bonobo feces and sequenced. By comparing the exon 2 and 3 sequences obtained 
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from all 255 fecal samples, we could define, unambiguously, which combination of exon 2 and 3 is present in 
each Papa-B allele (Supplemental Fig. 1). This approach defined 22 different Papa-B alleles (Fig. 2). Three 
of these, Papa-B*01:01, Papa-B*04:01, and Papa-B*07:01, were known from earlier studies of very small 
numbers of captive bonobos (39, 41). Thus, 19 of the Papa-B alleles identified in this study in wild bonobos 
are novel. 
 
Because the identity of the individual bonobo providing each fecal sample is unknown, we cannot discern 
precisely how many bonobos from each site contributed to our study. However, a minimum size for each 
population was obtained from the number of combined microsatellite genotypes, mitochondrial haplotypes, 
and Papa-B genotypes detected in the population (Fig.  2A, Supplemental Table Ia–f). In total, we studied a 
minimum of 110 bonobos, a comparable number to the 125 Gombe chimpanzees studied for Patr-B (32). 
Between 14 and 37 bonobos were studied for each of the five well-represented sites, and the two BJ samples 
came from different individuals (Fig. 2A, Supplemental Table Ia–f). Although both BJ samples typed 
identically as heterozygous for Papa-B*04:01 and Papa-B*09:01, they differ in microsatellite genotype 
(Supplemental Table If). In subsequent comparative analyses we will use the word “populations” to refer to 
the five well-represented sites. 
 
Between 3 and 14 Papa-B alleles were identified in each of five bonobo populations (Fig. 2A). Eight of the 
Papa-B alleles were found in only one of the five populations (Fig. 2B). In addition, a ninth allele, Papa-
B*04:01 was found only in the two BJ individuals (Fig. 2B). Ten of the Papa-B alleles were observed in two 
or three populations. In contrast, the Papa-B*07:01, Papa-B*09:01, and Papa-B*15:01 alleles were present 
in all five populations (Fig. 2B), and they were also among the most frequent Papa-B alleles (Fig. 2C), 
accounting for 44.1% of all Papa-B. With a frequency of 32.7%, Papa-B*07:01 has a significantly higher 
frequency than any other Papa-B allele (p < 0.0001, Fisher exact test). The genotype frequencies, for each 
population and for their combination, conform to Hardy–Weinberg equilibrium (GENEPOP v4.2, Hardy–
Weinberg exact test, using probability test) (Fig. 2C, Supplemental Table Ia–f). This result indicates that we 
have defined the common Papa-B alleles in the five populations and that any undetected allele has relatively 
low frequency. That Papa-B*04:01 was found only in BJ samples indicates that this eastern population of 
bonobos likely harbors additional novel Papa-B alleles. 
 
Bonobo and chimpanzee share a distinctive clade of MHC-B alleles 
 
Phylogenetic trees constructed from hominid MHC-B sequences typically show shallow branches and little 
evidence for long-lived alleles or allelic lineages (27, 32) [(Fig. 3A) (exon 2) and (Fig. 3B) (exon 3)] 
(Supplemental Fig. 2). An exception is a deeper branch formed by the exon 2 sequences of a trans-species 
clade of chimpanzee Patr-B, western gorilla Gogo-B, and human (Homo sapiens, Hosa, HLA-B) MHC-B 
alleles (28, 31, 32) (Fig. 3A, Supplemental Fig. 2). Defining this Hosa-Patr-Gogo clade (Clade 1) is a 
sequence motif in codons 62–74 of exon 2 (28, 32) (Fig. 3C, Supplemental Table Ih). Included in Clade 1 are 
human HLA-B*57:01 and chimpanzee Patr-B*06:03, alleles associated with control of the progression of 
HIV-1 and SIVcpz infection, respectively (31, 32, 62–67). Remarkably, no bonobo Papa-B allele clusters in 
this trans-species clade (Fig. 3A, Supplemental Fig. 2). Because this clade is predicted to have been present in 
the common ancestor of chimpanzee and bonobo, it appears to have been subsequently lost by the bonobo 
lineage. A possible factor contributing to this loss is that bonobos, unlike chimpanzees and humans, are not 







FIGURE  3. Two trans-species clades of MHC-B alleles. Neighbor-joining phylogenetic trees constructed 
from the sequences of exon 2 (A), which encodes the α1 domain, and exon 3 (B), which encodes the α2 
domain. Included are all bonobo Papa-B, chimpanzee Patr-B, and gorilla Gogo-B alleles, as well as 
representative human HLA-B alleles. Allele names are colored blue for Papa-B, and Patr-B are colored 
according to subspecies when known: green for western P. troglodytes verus, orange for central P. 
troglodytes troglodytes, and red for eastern P. troglodytes schweinfurthii. Representative HLA-B alleles are in 
bold black, and gorilla Gogo-B alleles are in purple. Nodal bootstrap values are based on 1000 replications. 
Nodes with <50% support were collapsed (full trees are shown in Supplemental Fig. 2). The brackets in (A) 
show two trans-species clades of alleles. Clade 1 contains HLA-B, Patr-B, and Gogo-B alleles (Hosa-Patr-
Gogo). Clade 1 was identified previously (28, 32) and contains alleles associated with control of HIV-1 
progression (HLA-B*57:01) and SIVcpz (Patr-B*06:03) infection (31, 32, 58–63). Clade 2, defined in this 
study, includes HLA-B, Patr-B, Papa-B, and Gogo-B alleles (Hosa-Patr-Papa-Gogo). HLA-B*27:05, in 
Clade 2, also associates with control of HIV-1 progression (61); however, its inclusion in the clade has weak 
support. HLA-B*27:05 differs from the clade Papa-B and Patr-B allotypes at key functional positions (63, 
70), which contribute to differences in their position 2 (P2) peptide-binding motif (C). Because arginine is the 
P2 residue of the HIV Gag KK10 epitope targeted by HLA-B*27:05 (48, 49), the associated protective 
effects of HLA-B*27:05 are unlikely to be preserved by Clade 2 bonobo and chimpanzee alleles, which are 
likely to bind peptides with P2 proline. (C) Table of amino acid sequence differences in residues 45–74 of the 
MHC-B α1 domain. Representatives of each sequence motif within this region for the alleles of tree (A) are 
included in the upper part. (The full allele set is given in Supplemental Table Ih). Allotype names are colored 
according to species or subspecies, as in (A). Identity to the consensus is denoted by a dash. The regions 
containing motifs that define Clade 1, positions 62–74 (28, 32), and Clade 2, positions 45–74 (Supplemental 
Fig. 3), are highlighted in tan. Additional HLA-B sequences with the Clade 2 motif are provided in the lower 
portion. Black-filled boxes between the two sets of sequences show the positions that contribute to binding 
sites for peptide, TCR, and KIR. Positions 45, 63, 66, 67, and 70 contribute to the B pocket of the MHC-B 
molecule, which binds the anchor residue, typically at P2, of nonamer peptides. The P2 residues for each 
MHC-B allotype [compiled from the SYFPEITHI database of MHC ligands and peptide motifs, 
http://www.syfpeithi.de/ (50) and from de Groot et al. (31)] are listed in the “Anchor” column. MHC-B P2 
residues that were inferred from known ligands are italicized and in gray type. 
 
Including Papa-B alleles in phylogenetic analysis of MHC-B revealed a second deep branch, Clade 2, which 
includes subsets of human, gorilla, chimpanzee, and bonobo MHC-B alleles (Fig. 3A, Supplemental Fig. 2). 
Defining Clade 2 is a sequence motif in codons 45–74 of exon 2 (Fig. 3C, Supplemental Fig. 3, Supplemental 
Table Ih). The key clade-defining residues are E45, M52, N63, A69, and Q70, as well as three alternative 
residues at position 67 (C, F, or Y) (Fig. 3C, Supplemental Table Ih). HLA-B allotypes in this clade 
underwent species-specific divergence, changing M52 to I52. Several of the clade-defining residues 
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contribute to the B pocket, which has a crucial role in binding peptides to MHC class I (72, 73). Comparing 
residues 45–74 of Clades 1 and 2 identifies eight positions of difference. The degree and pattern of sequence 
diversity within this region strongly suggest that Clade 1 and Clade 2 Papa-B bind distinct sets of peptide 
Ags, which also differ from those bound by other Papa-B (Fig. 3C, Supplemental Table Ih). 
 
The Clade 2 Papa-B and Patr-B alleles represent a lineage of Pan-B alleles that was present in the common 
ancestor of bonobos and chimpanzees. Consistent with this hypothesis, Papa-B*07:01 and Papa-B*09:01, 
both Clade 2 members, are present in the five bonobo populations (Fig. 2). Likewise for the chimpanzee, 
Clade 2 alleles were identified in three chimpanzee subspecies: two in western P. troglodytes verus, four in 
central P. troglodytes troglodytes, and two in eastern P. troglodytes schweinfurthii (Fig. 3A). (Nothing is 
known of Patr-B in the fourth chimpanzee subspecies, P. troglodytes ellioti.) Further supporting our 
hypothesis, some Clade 2 bonobo and chimpanzee alleles have identical exon 2 sequences. Papa-B*08:01 
shares exon 2 with Patr-B*12:02, and Papa-B*09:01 shares exon 2 with Patr-B*11:01 and Patr- B*11:02. It 
is most likely that the shared exons were inherited from the common ancestor of bonobo and chimpanzee. Of 
note, the exon 2 sequences of chimpanzee Patr-B*11:01 (28, 39), Patr- B*11:02 (27), and Patr-B*12:02 (27, 
28), which are shared with bonobo, have been found only in P.  troglodytes troglodytes, a  chimpanzee  
subspecies  whose  range  borders  that  of  bonobo (Fig. 1). 
 
Common and widespread Papa-B allotypes carry the Bw4 and C1 epitopes 
 
The peptide-binding domains of the 22 Papa-B allotypes differ at 32 positions of amino acid substitution (Fig. 
4). This compares with 57 positions for Patr-B and 178 for HLA-B. Almost all of the variable positions in 
Papa-B are associated with functional interactions of the α1 and α2 domains with peptide, TCR, KIR, and β2-
microglobulin (β2-m). The Papa-B α1 domain has more variable positions (n = 19) than the α2 domain (n = 
13). Of the 32 variable positions, 22 are dimorphisms, 8 are trimorphisms, and 2 display five alternative 
amino acid residues (Fig. 4). The 10 positions exhibiting more than two residues are evenly distributed 
between the two domains, but the α2 domain contains positions 116 and 156 that exhibit five alternative 
residues. Calculation of the Wu–Kabat coefficient of variability (54, 55) shows that position 156 in Papa-B 




FIGURE  4. High amino acid sequence variability in Papa-B focuses on position 156 in the α2 domain. The 
coefficient of amino acid sequence variability (W) for Papa-B allotypes is plotted in the bar graph. Only 
polymorphic positions are shown. The dotted line marks the value of W that is twice the mean value for W at 
all polymorphic positions. For positions that are not dimorphisms, the observed number of alternative amino 
acids is given above the bar. Amino acid sequence differences that distinguish the Papa-B allotypes are 
shown in the table. Identity to the consensus is denoted by a dash. Based on the criteria for phasing exon 2 
and exon 3 sequences, Papa-B*21:01 could not be assigned an α1 (exon 2) sequence (see Materials and 
Methods for details) (Supplemental Fig. 1). Clade 2 allotypes (Hosa-Patr-Papa-Gogo) are highlighted in gray. 
Pink boxes denote positions that contribute to binding sites for peptide, TCR, KIR, and β2-m, the invariant 
subunit of MHC class I. 
 
The Bw4 epitope recognized by KIR is defined by a sequence motif at positions 76–83 in the α1 domain (6, 
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11). Four bonobo allotypes have this sequence motif: Papa-B*07:01, Papa-B*02:02, Papa- B*13:01, and 
Papa-B*14:01 (Fig. 4). Together, they account for 47.7% of the Papa-B in the bonobo population (Figs. 2C, 
5). The C1 epitope recognized by KIR is defined by a sequence motif at positions 76 and 80 in the α1 domain 
(6, 11). Three bonobo allotypes have this motif: Papa-B*09:01, Papa-B*12:01, and Papa-B*20:01. These 
C1+ allotypes account for 11.8% of the Papa-B in the bonobo population. Papa-B*07:01 and Papa-B*09:01, 
both Clade 2 molecules and the most common Bw4+  and C1+  allotypes, respectively, are present in all five 
bonobo populations (Fig. 2, Supplemental Table Ia–f). Thus, we see a balance in bonobo populations be- 
tween three types of Papa-B allotypes: one having the Bw4 epitope, one having the C1 epitope, and one 




FIGURE  5. Pie chart of Papa-B allele frequencies in the study population of 110 bonobos. Alleles encoding 
the Bw4 KIR ligand are colored yellow, and those encoding the C1 KIR ligand are colored purple. Alleles 
that do not encode a KIR ligand are in shades of gray. Alleles present at >3% in the population are labeled. 
Papa-B*07:01, B*09:01, and B*15:01, highlighted by white boxes, are present in all five well-sampled 
bonobo populations. 
 
Bonobo Papa-B is less diverse than chimpanzee Patr-B and human HLA-B 
 
Among the 546 nucleotides of exons 2 and 3, 58 exhibit nucleotide variation among the 22 Papa-B alleles. 
This number is comparable to 59 positions in eight P. troglodytes troglodytes Patr-B alleles but is lower than 
the 86 positions present in 16 P. troglodytes schweinfurthii Patr-B alleles, the 91 positions present in 21 P. 
troglodytes verus Patr-B alleles, and the 88 positions present in 20 HLA-B alleles. These comparisons 
provided a first insight that Papa-B has more limited diversity than its orthologs in chimpanzee subspecies 
and humans. 
 
MHC-B diversity was further compared by analysis of the nucleotide differences (p-distance) between pairs 
of alleles from within each species or subspecies (Fig. 6). The mean p-distance of 0.041 for Papa- B (Fig. 
6A) is significantly less than the mean p-distances for P. troglodytes schweinfurthii Patr-B (mean = 0.058, p 
< 0.0001, Fig. 6B), P. troglodytes troglodytes Patr-B (mean = 0.052, p = 0.0015, Fig. 6C), P. troglodytes 
verus Patr-B (mean = 0.055, p < 0.0001, Fig. 6D), and HLA-B (mean = 0.055, p < 0.0001, Fig. 6E) (The 
statistical comparisons are also summarized in Supplemental Table Ii). Of note are the similar mean p-






FIGURE  6. Bonobo Papa-B has less nucleotide sequence diversity than chimpanzee Patr-B and human 
HLA-B. (A–E) Within-group comparisons of p-distances for MHC-B alleles (exons 2 and 3) are plotted as 
histograms. (F–O) Between-group comparisons. Mean p-distances (M) are given in the individual panels and 
are summarized in (P). N refers to the number of alleles. See Supplemental Table Ii for statistical results. 
Hosa, H. sapiens; Papa, P. paniscus; Pts, P. troglodytes schweinfurthii; Ptt, P. troglodytes troglodytes; Ptv, 
P. troglodytes verus. 
 
The p-distances were also calculated for comparisons between one Papa-B allele and one chimpanzee or 
human MHC-B allele. Comparison with P. troglodytes schweinfurthii Patr-B gave a mean p-distance of 0.055 
(Fig. 6F) compared with 0.048 with P. troglodytes troglodytes Patr-B (Fig. 6G), 0.060 with P. troglodytes 
verus Patr-B (Fig. 6H), and 0.060 with HLA-B (Fig. 6I) (p < 0.0001 for both Papa-Pts-Patr and Papa-Ptt-
Patr compared with Papa-Ptv-Patr, Supplemental Table Ii). This result shows that Papa-B is more similar to 
P. troglodytes schweinfurthii Patr-B and P. troglodytes troglodytes Patr-B, the two chimpanzee subspecies 
whose range borders that of bonobos, than to the more distant P. troglodytes verus chimpanzees. For 
interspecies comparisons involving one Papa-B allele, the range of mean p-distances is 0.048–0.60 (Fig. 6F–
I), whereas that for interspecies comparisons not involving a Papa-B allele is 0.056–0.065 (Fig. 6J–O). A 
summary of the mean p-distances is given in Fig. 6P (statistical comparisons are also summarized in 
Supplemental Table Ii). Thus, the nucleotide diversity of MHC-B in bonobo is significantly less than that in 
humans and each  of  the  three  chimpanzee  subspecies,  and  it  is  significantly more similar to that in P. 
troglodytes troglodytes and P. troglodytes schweinfurthii chimpanzees than in P. troglodytes verus 
chimpanzees. 
Comparison of Wu–Kabat variability coefficients (54, 55) shows that Papa-B also has the lowest variability in 
amino acid sequence (Fig. 7). In Papa-B, only position 156 has high variability, having more than twice the 
mean (Fig. 4, upper portion, Fig. 7A). This contrasts with six positions of high variability in P. troglodytes 
schweinfurthii Patr-B (Fig. 7B) and four in P. troglodytes verus Patr-B (Fig. 7C). Comparable differences are 
seen for human populations. The Hadza, hunter-gatherers from Tanzania (56) (Fig. 7D), Yucpa Amerindians 
(60) (Fig. 7F), and urban populations from Italy (57, 58) (Fig. 7G) and Uganda (61) (Fig. 7H) all have four 
highly variable positions, whereas the indigenous Taiwanese Tao population has only two (57, 58) (Fig. 7E). 
Like bonobos, position 156 is variable in P. troglodytes schweinfurthii chimpanzees and is dominated by 
nonpolar residues (Supplemental Table Ij). However, position 156 is approximately half as variable in P. 
troglodytes schweinfurthii chimpanzees as it is in bonobos (Fig. 7A, 7B). This difference is because Papa-B 
has a balance between leucine (22.7%) and tryptophan (31.8%), whereas Patr-B is biased toward leucine 







FIGURE 7. Comparison of MHC-B amino acid sequence variability in bonobo, chimpanzee, and humans. 
Plots of the coefficient of amino acid sequence variability (W) for MHC-B allotypes within bonobo (A), P. 
troglodytes schweinfurthii (Pts) chimpanzees (B), P. troglodytes verus (Ptv) chimpanzees (C), three 
indigenous human populations (D-F), and two urban human populations (G and H). N gives the number of 
allotypes for each population. Black bars represent positions with no sequence variability, gray bars represent 
dimorphic positions, and blue bars represent polymorphic positions. The dotted line is set at twice the mean 
value of W for all variable positions within a population. The pink boxes show the positions that contribute to 
human binding sites for peptide, TCR, KIR, the invariant subunit b2-m, and the CD8 T cell coreceptor (CD8). 
The Hadza (56), Tao (57, 58), and Yucpa (60) are indigenous human populations from Africa (Tanzania), Asia 
(Taiwan), and South America (Venezuela), respectively; Bergamo (57, 58) and Kampala (61) are admixed 
urban populations from Europe (Italy) and Africa (Uganda), respectively. 
ML bonobos maintain considerable diversity with only three Papa-B alleles 
Based on their mitochondrial DNA sequences, it has been sug- gested that bonobos subdivide into three 
geographically separate groups corresponding to the western, central, and eastern areas of their range (46) 
(Figs. 1, 2A). Of the sites that we studied, ML is western; LK, IK, BN, and KR are central; and BJ is eastern. 
Of the five well-represented sites, ML has only 3 Papa-B alleles compared with 10–14 alleles in the four 
central sites (Figs. 2A, 8A). The three Papa-B of ML bonobos represent distinct functional allotypes. Papa-
B*07:01 has the Bw4 epitope, Papa-B*09:01 has the C1 epitope, and Papa-B*15:01 has neither epitope (Figs. 
4, 5).  
ML bonobos maintain considerable nucleotide diversity, as assessed by mean pairwise difference (p-distance). 
Papa-B diversity is highest in ML, of intermediate value in LK, IK and BN, and lowest in KR (Fig. 8A). 
Papa-B diversity in central bonobo populations is significantly less than Patr-B diversity in wild P. 
troglodytes schweinfurthii Gombe  chimpanzees  (32)  and  a  captive P. troglodytes verus population (31) but 
is comparable to HLA-B diversity in four indigenous human populations (Fig. 8A, 8B). In contrast, Papa-B 
diversity in ML is comparable to that of chimpanzee Patr-B and human HLA-B (Fig. 8A, 8B) and is higher 
than the mean diversity for all possible combinations of three Papa-B alleles (Fig. 8C). Differences in amino 
acid sequence diversity are also seen among the five bonobo populations. In the LK, IK, BN, and KR 
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populations, position 156 stands out as the one highly variable position (Fig. 9), as also observed in the total 
bonobo population (Fig. 4, upper portion, Fig. 7A). Although ML has only three Papa-B allotypes, each has a 




FIGURE  8. Comparison of Papa-B diversity in the five bonobo populations. (A) Number of alleles and mean 
p-distances (± SEM) for MHC-B in the five bonobo populations and their comparison with chimpanzee and 
human populations. Representing indigenous chimpanzees are the wild Gombe P. troglodytes schweinfurthii 
(Pts) (32) and captive BPRC P. troglodytes verus (Ptv) (31) populations. The p values shown were calculated 
using an unpaired t test. *Statistical results of comparisons between bonobo populations and those of 
chimpanzees and humans are given in (B). The indigenous human populations represent Africa (Hadza, 
Tanzania) (56), East Asia (Tao, Taiwan) (57, 58), Melanesia (Asaro, Papua New Guinea) (59), and South 
America (Yucpa, Venezuela) (60). (B) The p values from comparisons of the p-distances of populations in (A) 
(unpaired t tests). (C) Distribution of mean p-distances for all possible trios of Papa-B alleles that can be 
permuted from the set of 22 Papa-B alleles (n = 1540). The dotted lines show the means for all possible Papa-






FIGURE  9. Comparison of Papa-B amino acid sequence variability in five bonobo populations. Plots of the 
coefficient of amino-acid sequence vari- ability (W) for the Papa-B allotypes of the five bonobo populations 
(numbers of allotypes are given in parentheses). The dotted line marks the value for W that is twice the mean 
W value for the polymorphic positions in each population. The number of alternative amino acid residues 
occurring at position 156 is shown above the bar. The pink boxes denote positions that contribute to human 
binding sites for peptide, TCR, KIR, and the invariant subunit β2-m. 
The bonobo populations differ in the frequency distribution of their Papa-B alleles (Fig. 10). Most similar are 
the IK and BN bonobos (Fig. 10) that live at closely located sites in the central range (Fig. 1). The frequency 
of Papa-B allotypes that have the Bw4 epitope is similar (36.4–41.7%) in the three most central sites (IK, BN, 
and KR), but it is higher in the more western populations (67.6% in LK and 78.6% in ML) (Fig. 10A). The 
frequency of Papa-B allotypes having the C1 epitope is similar (8.8–11.4%) in four of the populations but is 
noticeably higher in ML (14.3%). In all five populations, the Papa-B*07:01 allele, encoding the Bw4 epitope, 
is the most frequent or the second most frequent Papa-B allele (Fig. 10B, 10C). In ML, the Papa-B*07:01 
allele is particularly dominant (Fig. 10C). A less extreme dominance by one MHC-B allele is seen in the 
captive P. troglodytes verus chimpanzee population, as well as in the Hadza and Tao human populations (32) 
(Fig. 10C). Like the Gombe chimpanzees, the LK and KR bonobo populations have two high-frequency 
alleles and a majority of low-frequency alleles (32). In the IK and BN populations, there is a less skewed 





FIGURE  10. MHC-B allele distribution in bonobo, chimpanzee, and human populations. (A) Pie charts for 
each population show the proportions of Papa-B alleles that encode the Bw4 epitope (shades of yellow) or the 
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C1 epitope (shades of purple). Alleles not encoding Bw4 or C1 are shaded gray. Each pie segment 
corresponds to a different allele. Segments in different pies that have identical yellow or purple color denote 
the same allele, but alleles in the same shade of gray are not necessarily the same allele. The frequencies, as 
percentages, for the alleles encoding an epitope recognized by KIR (Bw4 or C1) and alleles that encode 
neither epitope (None) are shown for each population. (B) Pie charts for each population showing frequencies 
of the 22 Papa-B alleles. Each allele is defined by a different color (same in each pie). Segments are organized 
in order of decreasing frequency. (C) Comparison of the distributions of MHC-B allele frequency in five 
bonobo populations (upper panels), two chimpanzee populations (lower left panels), and four human 
populations (lower right panels). The bars show the MHC-B allele frequencies in descending order. The bar 
graphs for the bonobo populations use the same color scheme as in (B) to distinguish the Papa-B alleles. For 
the chimpanzee and human, each population is distinguished by bars of a different color, but all alleles are 
colored identically within a population. The Gombe chimpanzees are the P. troglodytes schweinfurthii (Pts) 
subspecies (32), and the BPRC population is the P. troglodytes verus (Ptv) subspecies (31). HLA-B allele 
frequencies are also shown for the Hadza (56), Tao (57, 58), Kampala (61), and Bergamo (57, 58) human 
populations. The Hadza and Tao are indigenous populations from Africa (Tanzania) and Asia (Taiwan), 
respectively; Kampala and Bergamo are admixed urban populations from Africa (Uganda) and Europe (Italy), 
respectively. N shows the number of individuals analyzed. Allele frequencies were compared using the Fisher 
exact test. The narrower black brackets (ML, BPRC, Hadza, Tao) denote that the most common allele is 
significantly more frequent than the second most common allele; the wider black brackets (KR, Gombe) show 
that the two most common alleles are significantly more frequent than the third most common allele but do not 
differ significantly from each other (p values are given below the bracket; p < 0.0001 applies to both high-
frequency Gombe alleles). In LK, the most common allele is significantly more frequent than the third most 




Bonobos and chimpanzees are sibling species and humans’ closest relatives (36). These great apes are 
invaluable for understanding all aspects of human evolution. This is particularly true for the highly 
polymorphic MHC class I genes that function in innate immunity, adaptive immunity, and reproduction (6, 
11). Strict orthologs of all of the classical human MHC class I genes (HLA-A, HLA-B, and HLA-C) are present 
only in great apes (10). Moreover, it is in chimpanzee and bonobo that the organization of the MHC class I 
gene family is most like that of humans (10, 11, 38). Although there has been steady acquisition of knowledge 
of the chimpanzee MHC since the late 1980s (10, 27, 28, 74, 75), next to nothing is known about the bonobo 
MHC (10, 38–42). Emphasizing this paucity, the numbers of MHC-B sequences currently deposited in MHC 
databases are 8 for bonobo, 64 for chimpanzee, and 4647 for human (43, 44). The eight Papa-B sequences 
were derived from captive bonobos of unknown provenance (39, 41). 
In contrast, we studied Papa-B in six populations of wild-living bonobos (45). This approach enabled us to 
study the polymorphism of Papa-B and place it in the context of the bonobo’s natural population structure. In 
studying ≥110 individuals, we identified 22 Papa-B alleles among the six populations. This number compares 
with the 11 Patr-B alleles present in 125 chimpanzees, forming three communities, in Gombe National Park of 
Tanzania (32) (Fig. 1). The set of Papa-B alleles is less diverse than comparable sets of HLA-B and Patr-B 
alleles, and this holds true even when Patr-B are limited to those alleles of a single chimpanzee subspecies. 
Our results are consistent with whole- genome comparisons, which concluded that bonobos experienced a 
severe population bottleneck and consequently exhibit a strong signature of inbreeding (36). 
Phylogenetic analysis identified two trans-species clades of MHC-B that are defined by sequence motifs in 
part of the Ag- recognition site contributed by the α1 domain. The Pan clade (Clade 2) is broadly conserved 
among African apes, including some Papa-B of bonobo and Patr-B of the three chimpanzee subspecies 
studied, as well as some gorilla Gogo-B. The other trans-species MHC-B clade (Clade 1), which includes 
some human, chimpanzee, and gorilla MHC-B alleles (28, 32), correlates with resistance to disease 
progression of human HIV-1 (HLA- B*57:01) and chimpanzee SIV (Patr-B*06:03) infections (31, 32, 62–67). 
However, none of the 22 Papa-B alleles are part of Clade 1. This absence could be due to insufficient 
sampling of bonobo populations. In this regard, it is unfortunate that we had only two samples from the BJ 
site. This population is separated from the other populations by the Lomami River (Fig. 1B), which is a known 
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barrier to bonobo gene flow (46, 76). The possibility of BJ bonobos having Papa-B alleles that eluded our 
analysis is likely, because Papa-B*04:01 was found only in the two BJ bonobos. A relevant and intriguing 
fact is that SIV has never been detected in bonobos, either in the wild or captivity (45, 77). In contrast, two of 
the four chimpanzee subspecies (Fig. 1A), P. troglodytes troglodytes and P. troglodytes schweinfurthii, have 
endemic SIVcpz infection (69). It is possible that Clade 1 Papa-B alleles are present at low frequency within 
bonobos, in the absence of pressure from SIV infection to drive them to higher frequency. Alternatively, 
Clade 1 was present in the common ancestor of chimpanzee and bonobo but was subsequently lost on the 
bonobo branch. 
The ML population provides an informative example of a population bottleneck in bonobos. Of similar size to 
the LK and IK populations, ML has only 3 Papa-B alleles compared with 10 in LK and 11 in IK. For 
comparison, the South Amerindian Yucpa, a small and bottlenecked human population, has seven HLA-B 
alleles (60). One important characteristic of the three ML Papa-B allotypes (Papa-B*07:01, Papa-B*09:01, 
and Papa-B*15:01) is that they are the only Papa-B present in all five well-sampled study populations. A 
second important characteristic is that they represent three functionally distinctive groups of Papa-B. Papa-
B*07:01 has the Bw4 epitope recognized by KIR (6, 11). Papa-B*09:01 carries the C1 epitope, also 
recognized by KIR (6, 11). In contrast, Papa- B*15:01 has neither Bw4 nor C1 and, thus, is dedicated to 
presenting peptide Ags to the AgRs of CD8 T cells. Their presence in all populations and retention through 
the bottleneck experienced by ML bonobos indicate that this combination of three Papa-B allotypes has been 
essential for the survival of bonobo populations. Supporting this hypothesis, the sequence differences among 
these allotypes give ML bonobos the highest nucleotide diversity of the five populations. Moreover, this 
diversity is higher than the mean p-distance of all possible combinations of three Papa-B alleles. 
Conservation of Bw4 and C1 in the five bonobo populations points to the importance that interactions of these 
epitopes with KIR could have in the education and immune response of bonobo NK cells (6, 11). Comparison 
of the human and chimpanzee KIR families identified similarities in their component KIR but differences in 
the organization of the KIR locus (11, 35). Chimpanzee KIR haplotypes are variations on a theme of multiple 
strong inhibitory HLA-C receptors (33, 35). In contrast, the human KIR locus has two distinctive forms that 
are present and balanced in all human populations (6, 60). Human KIR A haplotypes are similar to chimpanzee 
KIR haplotypes, whereas human KIR B haplotypes have genes encoding additional activating KIRs and 
weaker inhibitory KIRs (6, 22, 35). The KIR A and B haplotype difference influences NK cell responses and 
correlates with a wide range of infectious and inflammatory diseases, as well as pregnancy syndromes and 
outcomes of clinical therapies, notably hematopoietic cell transplantation (25, 26, 78–82). A first analysis of 
the bonobo KIR region showed that it is different again from both the chimpanzee and human KIR loci (37). 
Bonobo KIR haplotypes form two distinctive groups, with even frequencies in the cohort of nine captive 
bonobos studied (37). One haplotype group resembles chimpanzee KIR haplotypes (11, 35, 37). The other 
group has contracted in size, leaving only the conserved framework genes that define the ends and the center 
of the KIR locus (37). Missing are the genes that, in humans, encode the KIRs that recognize Bw4 and C1. 
This division of bonobo KIR haplotypes into two qualitatively different groups parallels the division of the 
human KIR locus into A and B haplotypes (11, 37) and contrasts with the chimpanzee KIR locus (11, 35). In 
humans, there is increasing evidence that the KIR A and KIR B haplotype difference evolved as a compromise 
between NK cell functions in immunity and reproduction (6, 22). That could also be the case for the bonobo 
KIR haplotype groups. The considerable insight gained from this population study of one bonobo MHC class I 
gene makes targeted capture and next-generation sequencing of entire bonobo MHC and KIR regions an 
exciting proposition. A method for such analysis of human HLA and KIR has proved applicable to chimpanzee 
and should also apply to bonobo (20, 83). 
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Supplemental Figure 1. Examples of Papa-B allele inferences. (A) Exons were assumed to be from the same 
allele when both the exon 2 and 3 sequences amplified were identical to those of a previously defined allele. 
For example, from one fecal DNA sample, exon sequences identical to those of Papa-B*07:01 were observed 
for both exon 2 (Papa-B2*07:01) and exon 3 (Papa-B3*07:01) (in blue). They were thus assumed to be from 
the same Papa-B*07:01 allele (connected by a solid arrow). For a heterozygous individual containing Papa-
B*07:01, the other exon 2 and 3 pair was then inferred to be an allele (in shades of red, connected by a dashed 
arrow). (B) Most exon 2 and 3 pairs were amplified from more than one fecal DNA sample and in different 
heterozygous combinations. In this case, the pair of repeated exons was inferred to represent one allele, and the 
other pair was the second allele. For example, hypothetical exons Papa-B2*D and Papa-B3*W (in shades of 
yellow) were observed with two different companion pairs of exons (in shades of pink and purple) in different 
samples. In this case, we would infer that Papa-B2*D and Papa-B3*W were parts of the same allele (connected 
by a solid arrow); likewise, the other exon pairs would be assigned to the same allele (connected by a dashed 
arrow). (C) Conservatively, we assigned only an exon 3 sequence as Papa-B*21:01. The Papa-B3*21:01 exon 
3 sequence (light orange) was amplified from one fecal DNA sample (Sample 1). That sample was 
heterozygous for exon 3 but homozygous for exon 2. Because the Papa-B2*17:01 and Papa-B3*17:01 exon 
sequences (in green) had been detected together in other samples, but with different companion exons 2 and 3 
(e.g. Sample 2), we assumed they were parts of the same allele, per the guidelines outlined in (B). However it 
was unclear whether the single exon 2 sequence (Papa-B2*17:01) should also be paired with Papa-B*21:01 
(exon 3) or whether the companion exon 2 sequence of Papa-B*21:01 failed to amplify (shown by dashed 




Supplemental Figure 2. Hominid MHC-B phylogeny.  
Complete neighbor-joining trees corresponding to the condensed trees shown in Fig. 3A, B and Supplemental 
Fig. 3A. The tree is constructed from the exon 2 (A) and exon 3 (B) nucleotide sequences of all bonobo Papa-
B, chimpanzee Patr-B, and gorilla Gogo-B, as well as representative human HLA-B alleles. Two trans-species 
clades of MHC-B alleles were identified from exon 2 sequences: Clade 1 (gray box) was defined previously (1, 
2) and contains HLA-B, Patr-B, and Gogo-B alleles (Hosa-Patr-Gogo), and Clade 2 (yellow box) includes 






Supplemental Figure 3. Codons 45-74 define hominid MHC-B Clade 2: Hosa-Patr-Papa-Gogo. Shown are 
neighbor-joining phylogenetic trees for all bonobo Papa-B, chimpanzee Patr-B, and gorilla Gogo-B alleles, and 
representative human HLA-B alleles. A tree based on exon 2 sequences shows two trans-species clades (A) 
(also Fig. 3A). The gray box denotes Clade 1 (Hosa-Patr-Gogo) containing alleles from humans, chimpanzees, 
and gorillas. Clade 1 includes HLA-B*57:01 and Patr-B*06:03, alleles correlated with control of progression 
of HIV-1 and SIVcpz infections, respectively (1, 3-9). This clade was identified previously and shown to be 
defined by residues at positions 62-74 (1, 2). The yellow box denotes Clade 2 (Hosa-Patr-Papa-Gogo), which 
contains human, chimpanzee, bonobo, and gorilla MHC-B alleles. Clade 2 is maintained in trees constructed 
from the sequence of codons 45-74 (B), but not in trees constructed from exon 2 sequences with these codons 
deleted (C). Thus the amino acid motif at positions 45-74 defines Clade 2. Nodal bootstrap values are based on 
1000 replications, with nodes having <50% support being collapsed.  
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